FDI of the Month February 2023: Siemens Healthineers launch laboratory equipment centre in Swords

FDI of the Month, R+D | Thu 2 Mar | Author – Business & Finance

Following a multi-million-euro investment from Siemens Healthineers, with support from IDA Ireland, a new Centre of Excellence for Immunoassay Instrument R&D will open in Swords, Ireland.

Siemens Healthineers has launched a new Centre of Excellence for Immunoassay Instrument Research and Development (R&D) in Swords, Ireland.

The centre will focus on developing innovations in laboratory instruments used to detect infectious diseases, cancer and blood disorders, and will result in the creation of 100 proposed new jobs.

65 of those jobs will be ‘high-level’ engineering roles in artificial intelligence, machine learning, software engineering, systems engineering and data science.

The investment will span multiple years.



FDI of the Month January 2023: Fidelity Investments

FDI of the Month December 2022: Pfizer


Clinicians can now also “optimise patient care by bringing new levels of precision” to the diagnostic laboratories that serve them, said Siemens Healthineers in a press release.

Taoiseach Leo Varadkar TD led congratulations, stating: “This is a significant expansion with the creation of 100 new jobs, the majority of which will be highly skilled, providing great opportunities for engineers.

“This new centre is testament to Ireland’s strong reputation for R&D. Exciting new technology like that which will be developed in Swords, can make a real difference to people’s lives, to patient outcomes and to healthcare systems globally. I wish the team at Siemens Healthineers the very best for many successful years and continued growth in Ireland.”

“The investment at Swords will build on our existing expertise in healthcare manufacturing, adding a critical research and development focus,” statesDr Dennis Gilbert, Head of R&D for Siemens Healthineers Diagnostics.

“Partnering with IDA has enabled us to move forward in ways that would not have otherwise been feasible and will allow us to pioneer breakthroughs in healthcare, helping hospitals and laboratories across the globe to diagnose disease more effectively and efficiently.”

“This is an exciting opportunity for us to create an entrepreneurial research environment, while leveraging the strength and breadth of all that Siemens Healthineers has to offer,” states Fred O’Brien, VP of Manufacturing and Managing Director of Swords for Siemens Healthineers.

“It highlights the calibre of the existing team and with this investment we will create a hub of skilled and experienced engineers and researchers, broadening the scope of careers in the local area.”

Siemens Healthineers has been active in Swords supplying medical diagnostic equipment to hospitals and laboratories since 1966.